Dostinex Cabergoline 0.25mg 100pcs Oral Steroids Tablets

Description

Cabergoline Dostinex Dopamine D2 Agonist Research

How It Works

The biochemical activity of Cabergoline is defined by its potent and selective interaction with dopamine D2 receptors on pituitary lactotroph cells. Initially, the molecule binds to these receptors with high specificity, mimicking the inhibitory action of endogenous dopamine. This defines the first semantic triple: [Cabergoline binds pituitary D2 receptors]. Additionally, this engagement initiates an inhibitory G-protein signaling cascade that reduces the intracellular concentration of cyclic adenosine monophosphate (cAMP). This establishes the second triple: [D2 activation decreases intracellular cAMP]. Thirdly, the resulting suppression of cAMP inhibits the synthesis and pulsatile release of prolactin into the systemic circulation. This forms the third triple: [Prolactin reduction optimizes the HPTA]. Quantitatively, Cabergoline demonstrates a prolonged terminal half-life of approximately 65 hours ($t_{1/2}=65pm4$h), facilitating infrequent research administration. Unlike Bromocriptine, which requires daily dosing and exhibits lower D2 selectivity, Cabergoline offers superior receptor occupancy and a significantly reduced side-effect profile in laboratory models.

Product Profile

Cabergoline Dostinex is a synthetic ergot derivative and long-acting dopamine receptor agonist with a high affinity for the D2 receptor subtype. This signaling molecule serves as a primary research benchmark for investigating the suppression of prolactin secretion and the modulation of the dopaminergic system. [Cabergoline agonizes the D2 receptor]. It is utilized in specialized research models to evaluate neuroendocrine homeostasis without the rapid clearance associated with earlier-generation compounds.

Specification Sheet

• CAS Number: 81409-90-7
• Molecular Formula: C26H37N5O2
• Molecular Weight: 451.6 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: White crystalline powder

Known Effects

• Significant Prolactin Suppression: Users in research models report a rapid and sustained decrease in serum prolactin levels.
• Enhanced Libido and Sexual Function: Controlled trials show marked improvements in sexual desire and a significant reduction in the refractory period.
• Optimization of the Refractory Period: Based on community feedback, research shows that lowering prolactin facilitates faster physiological recovery between mechanical stimulus events.
• Mood and Motivation Support: Cumulative findings indicate improved mental clarity and drive, likely due to increased dopaminergic signaling.
• Prevention of Tissue Sensitivity: Research models have observed that managing prolactin assists in mitigating certain sensitivity issues when used alongside aromatizing compounds like Test Enanthate or Tren Acetate.

Key Points:
Cabergoline Dostinex represents a premier research tool for investigating the targeted inhibition of prolactin and the molecular pathways of dopaminergic signaling.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.